EEFT vs REGN · P/E 11, rev $3.99B vs P/E 14, rev $14.34B
Euronet Worldwide Inc (EEFT) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Euronet Worldwide Inc (EEFT) is a software - infrastructure company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported EEFT revenue for 2024-12-31 was $3.99B. Net income was $306.3M. Revenue was up 8.2% from 2023-12-31 to 2024-12-31. EEFT currently screens at market cap $2.76B and trailing P/E 10.6.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
EEFT currently screens at market cap $2.76B and trailing P/E 10.6. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the EEFT and REGN stock pages for the full models.
Not investment advice.